Please RSVP by filling out the form below.
This event is hosted by the Academic, Research, and Careers (ARC) committee of the Graduate Student Council (GSC).
More info about PDS:
http://gsc.mit.edu/programs-initiatives/pds/ "An entrepreneurial path from IT to Biotechnology with a little help from MIT"
by Jeff Behrens
When: Friday, April 20, 11.30am - 1pm
Where: E51-345
Jeff Behrens is currently Senior Director, Business Development and Operations at Edimer Pharmaceuticals which is focusing on developing a treatment for a rare genetic disease – XLHED (X-linked hypohidrotic ectodermal dysplasia). Edimer is funded by Third Rock Ventures in Boston and VI Partners in Switzerland. Jeff has broad responsibilities with manufacturing, finance, operations, and business development/alliance/partnering.
Formerly, Jeff was Director, Strategic Alliances at Alnylam and Co-founder and Head of Business Operations of "BI3" - The Biogen Idec Innovation Incubator - where he founded and launched two companies funded by Biogen Idec – Escoublac and Provasculon - working on diabetes and cardiovascular indications.
In 2003 Jeff sold his health-care IT company, The Telluride Group, to mindSHIFT Technologies, a Fidelity-funded rollup. Telluride was an angel financed managed services provider (MSP).
Jeff is currently an Entrepreneur In Residence at the MIT Sloan Entrepreneurship Center, a member Mass Medical Angels, and a mentor with MIT’s Venture Mentoring Service. Jeff volunteers with several community organizations including the Harvard Alumni Association and sits on the boards of Tufts Medical Center and The Speakeasy Stage Company in Boston.
Jeff has a Lecturer appointment and currently teaches in the HST PhD program at MIT and Harvard Medical School. Jeff has an MS from the Harvard/MIT Division of Health Sciences and Technology (HST), an MBA from MIT Sloan, and graduated from Harvard College. He lives in Newton, MA.